After losing some value lately, a hammer chart pattern has been formed for Emcor Group (EME), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

After losing some value lately, a hammer chart pattern has been formed for Profound Medical (PROF), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

The mean of analysts' price targets for LATAM (LTM) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

After losing some value lately, a hammer chart pattern has been formed for Veritone (VERI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

The mean of analysts' price targets for MediaAlpha (MAX) points to a 34.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Orion Marine (ORN) points to a 30.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in vTv Therapeutics (VTVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 51.2% upside potential for Liquidia Corporation (LQDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

In the Core Value category, our biggest detractors were Baxter International (BAX) and Philip Morris International (PM). Another decliner was Kerry (KRYAY), the largest food and beverage ingredients company globally, which we classify as a Dividend Growth name. On the positive side, top performers included Polaris (PII), nVent Electric (NVT) and Lam Research (LRCX).

BioLineRx Ltd. ( BLRX ) Q3 2025 Earnings Call November 24, 2025 8:30 AM EST Company Participants Irina Koffler - Managing Director Philip Serlin - Chief Executive Officer Mali Zeevi - Chief Financial Officer Ella Sorani - Chief Development Officer Conference Call Participants Joseph Pantginis - H.C.

Green Dot Corporation ( GDOT ) Smith Ventures, - M&A Call November 24, 2025 8:30 AM EST Company Participants Timothy Willi - Senior Vice President of Finance & Corporate Development William Jacobs - Interim CEO & Chairman of the Board Jess Unruh - Chief Financial Officer Bill Smith Kenneth Till - CEO & Director Conference Call Participants George Sutton - Craig-Hallum Capital Group LLC, Research Division Cristopher Kennedy - William Blair & Company L.L.C., Research Division Mike Grondahl - Northland Capital Markets, Research Division Presentation Operator Good day, and welcome to the Green Dot Commerce One Smith Ventures Transaction Conference …

KalVista Pharmaceuticals, Inc. ( KALV ) Jefferies London Healthcare Conference 2025 November 19, 2025 8:30 AM EST Company Participants Benjamin Palleiko - CEO & Director Conference Call Participants Maurice Raycroft - Jefferies LLC, Research Division Presentation Maurice Raycroft Jefferies LLC, Research Division Hi, everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies.

Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Toronto Stock Exchange (TSX) welcomed special guests to celebrate the kickoff of the first Canada Climate Week Xchange (CCWX). Cannot view this video?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

In Q3, we initiated new positions in Accenture (ACN) and Constellation Brands (STZ). Like all technological innovations, AI should create both winners and losers. We exited Altria (MO), a tobacco company, and Atmos Energy (ATO), a natural gas distributor, choosing to recycle capital into more attractive opportunities as both stocks reaching our target selling ranges.

LOS ANGELES, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 26, 2024 and September 17, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 26, 2025.

LOS ANGELES, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie” or “the Company”) (NYSE: JHX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 20, 2025, and August 18, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 23, 2025.